Light helmet for Alzheimer's shows promise, but study cut short

NCT ID NCT03672474

Terminated Symptom relief Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a special helmet and abdominal panel that shines near-infrared light and uses a static magnetic field on people with mild-to-moderate Alzheimer's disease. The goal was to see if it could safely improve memory and thinking. The study planned to enroll 60 participants but was terminated early, so we don't have full results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Photobiomodulation device (helmet and abdominal panel with near-infrared lasers, LEDs, and static magnetic field)
What this could lead to: If it works, this could point toward a non-drug way to slow cognitive decline in Alzheimer's patients.
What could go wrong: The study was terminated early, so we don't have clear results. It was a small pilot trial, and previous anti-amyloid approaches have failed, so success is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE

Contacts and locations

Locations

Montpellier University Hospital, Gui de Chauliac

Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.